Eval CR 300 mg (Tablet (Controlled Release))

Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)
Strip Price: ৳ 80.00

Medicine Details

Indications

  • Treatment of all types of epilepsy
  • Prophylaxis of febrile convulsion
  • Prophylaxis of post-traumatic epilepsy
  • Treatment of bipolar disorder
  • Prophylaxis of migraine

Composition

  • Enteric-coated tablets with Sodium Valproate BP 200 mg
  • Syrup with Sodium Valproate BP 200 mg per 5 ml
  • Controlled release tablets with different strengths of Sodium Valproate and Valproic acid
  • Injectable solution with Sodium Valproate BP equivalent to Valproic Acid 500 mg per 5 ml

Pharmacology

  • Sodium Valproate endowed with anti-epileptic activity
  • Mechanism of action possibly related to increased brain levels of gamma-aminobutyric acid (GABA)

Dosage & Administration

  • Oral administration for epilepsy, bipolar disorder, and prophylaxis of migraine
  • Initial and maintenance doses for adults and children
  • Injection dosage for adults and children
  • Recommendation to administer after food

Interaction

  • Non-specific inhibitor of drug metabolism
  • Significant interactions with Phenobarbital, Phenytoin, Warfarin, Aspirin, etc.

Contraindications

  • Known hypersensitivity to the drug
  • Liver dysfunction
  • Restricted use during pregnancy and in women of childbearing potential

Side Effects

  • Common side effects like anorexia, nausea, and vomiting
  • Effects minimized with enteric-coated tablets
  • CNS effects including sedation, ataxia, and tremor
  • Rare occurrence of rash, alopecia, and stimulation of appetite
  • Elevation of liver enzymes observed in up to 40% of patients
  • Potential for fulminate hepatitis, acute pancreatitis, and hyperammonemia

Pregnancy & Lactation

  • Crosses the placenta
  • Associated with neural tube defects in newborn if exposed during the first trimester
  • Excreted in breast milk with no significant risk to the child

Precautions & Warnings

  • Monitoring of liver functions before therapy and during the first 6 months
  • No undue potential for bleeding before major surgery
  • Care in renal impairment, pregnancy, and breast-feeding
  • Elimination in urine may lead to false interpretation of urine ketone test
  • Sudden withdrawal should be avoided

Therapeutic Class

  • Primary anti-epileptic drugs

Storage Conditions

  • Do not store above 30°C
  • Keep away from light
  • Keep out of the reach of children

Related Brands